论文部分内容阅读
我科于1997年9月至1998年4月,对68例脑梗死患者分别采用东美克栓酶和降纤酶进行治疗,结果报道如下。 资料与方法 1.临床资料对象均符合第四届全国脑血管疾病会议修订的诊断标准,经颅脑CT或MRI检查确诊为脑梗死。将入选者随机分为两组:(1)东菱克栓酶治疗组37例,男20例,女17例,年
Our department from September 1997 to April 1998, 68 patients with cerebral infarction were treated with Dongmeak thrombin and defibrase, the results reported below. Materials and Methods 1. Clinical data subjects were in line with the Fourth National Conference on cerebrovascular disease revised diagnostic criteria, by brain CT or MRI examination confirmed cerebral infarction. The participants were randomly divided into two groups: (1) 37 cases of tangling Kexue treatment group, 20 males and 17 females,